Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Two Chemotherapy Regimens Plus or Minus Bevacizumab [Phase 2]
This Phase 2 trial in pancreatic cancer compares two chemotherapy regimens with or without bevacizumab and is currently active but not recru…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer [Phase 4]
Phase 4 clinical trial evaluating Huaier Granule as postoperative adjuvant therapy for resectable pancreatic cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors [Phase 1]
Phase I clinical study of QLC1101 in patients with advanced solid tumors, including non-small cell lung cancer and colorectal cancer; the st…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis [Phase 2]
A Phase 2 clinical trial is evaluating Nimotuzumab in combination with AG for pancreatic cancer with liver metastasis; the current status is…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD [Phase 2]
Phase II study evaluating surufatinib in combination with camrelizumab and the mFOLFOX6 regimen as second-line treatment for advanced pancre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic Cancer
A completed clinical trial update describing the absence or lack of adjuvant therapy following pancreatic cancer resection.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Evaluation of Nutritional Scores as Predictive Factors of Postoperative Outcome After Pancreatic Surgery
Completed clinical trial evaluating whether nutritional scores can predict postoperative outcomes after pancreatic surgery.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Olaparib in PALB2 Advanced Pancreatic Cancer [Phase 2]
A Phase 2 study evaluates olaparib in PALB2-associated advanced/metastatic pancreatic cancer; the trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients [Phase 1]
Phase 1 clinical trial evaluating 89Zr-MMOT PET imaging in pancreatic and ovarian cancer patients has completed.
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Multimodal Imaging in Rectal Cancer & Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update describes Phase 1 and Phase 2 studies evaluating multimodal imaging approaches in rectal cancer and pancreatic ca…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies [Phase 2]
Phase 2 trial evaluating high-dose intravenous vitamin C in patients with resectable or metastatic solid tumors has completed, with results …
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating sequential AG and mFOLFOX chemotherapy with serplulimab and bevacizumab in untreated advanced pancreatic c…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery [Phase 3]
A Phase 3 trial evaluating ctDNA-guided treatment for localized pancreatic cancer, comparing neoadjuvant CTX chemotherapy to upfront surgery…
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
An ongoing long-term observational study is evaluating disease-free survival and overall survival for the adjuvant FOLFIRINOX regimen in pan…
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer [Phase 4]
A Phase 4 study evaluating Huaier Granule for unresectable pancreatic cancer, sponsored by Xi'an Jiaotong University. The trial status is no…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours [Phase 1, Phase 2]
Phase 1/2 study evaluating the safety, pharmacokinetics, and efficacy of the MYC-inhibitor OMO-103 in solid tumors, including pancreatic and…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update comparing HR070803 with Oxaliplatin and S-1 versus NALIRIFOX as adjuvant therapy for pancreatic cancer; the st…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: PRIORITY-CONNECT 2 Pilot Trial [NA]
The PRIORITY-CONNECT 2 Pilot Trial is currently recruiting. Sponsored by the Surgical Outcomes Research Centre, the study investigates liver…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Saltikva for Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for Saltikva in metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant chemoradiation with gemcitabine and durvalumab followed by adjuvant gemcitabine and durvalumab in resec…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer [Phase 2]
Phase 2 trial update evaluating pembrolizumab plus chemotherapy as first-line treatment for pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for childhood recall antigens in patients with pancreatic cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for disitamab vedotin in locally advanced or metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy [Phase 3]
A Phase 3 trial comparing chemoradiation versus chemotherapy alone after induction chemotherapy in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX [Phase 2]
Phase 2 trial evaluating prophylactic Neulapeg (Pegteograstim) in patients with locally advanced or metastatic pancreatic cancer receiving m…